Explainer
Does insurance cover GLP-1 weight-loss medications?
By the TreatmentMD editorial team

Key takeaways
- Coverage for weight loss depends mostly on your plan, and Medicare now covers some GLP-1s for $50 a month for people who qualify.1KFFSourceKFF. 2025 Employer Health Benefits Survey. October 22, 2025.Open the source All sources2Centers for Medicare and Medicaid ServicesSourceMedicare.gov. Weight loss drugs: the Medicare GLP-1 Bridge. Checked October 6, 2026.Open the source All sources
- Plans that cover them usually ask for a BMI of 30, or 27 with a weight-related condition, and an approval your clinician requests.3Cigna HealthcareSourceCigna Healthcare. Drug Coverage Policy IP0206: Weight Loss, Glucagon-Like Peptide-1 Agonists (Foundayo™). Effective September 1, 2026.Open the source All sources4Novo NordiskSourceNovoCare. Check your coverage for Wegovy®. Checked October 6, 2026.Open the source All sources
- If your plan says no, you still have good options, from cash prices to online programs that don't need insurance at all.
By the TreatmentMD editorial team
Insurance is often one of the first things people wonder about with a GLP-1. Fair question, since these medicines aren't cheap.
The short answer is sometimes. It depends more on your plan than on the medicine. And you can find out where you stand before you start.
Here's how coverage works, and what to do whichever answer you get.
01The short answer
Does insurance cover GLP-1s for weight loss?
Sometimes. Each plan decides whether it pays for weight-loss medicines at all. With a plan through work, that's usually your employer's call. So two people with the same insurer can get different answers.5UnitedHealthcareSourceUnitedHealthcare. Prior Authorization/Notification, Weight Loss/Appetite Suppression Medication Coverage, program 2026 P 1114-23. Effective October 1, 2026.Open the source All sources
In 2025, about 1 in 5 employers with 200 or more workers covered GLP-1s for weight loss. Among the biggest, with 5,000 workers or more, it was 43%.1KFFSourceKFF. 2025 Employer Health Benefits Survey. October 22, 2025.Open the source All sources
Here's how it usually looks, by type of coverage:
| For weight loss? | Good to know | |
|---|---|---|
| A plan through work | Sometimes | Your employer decides5UnitedHealthcareSourceUnitedHealthcare. Prior Authorization/Notification, Weight Loss/Appetite Suppression Medication Coverage, program 2026 P 1114-23. Effective October 1, 2026.Open the source All sources |
| A Marketplace plan | Rarely | A few plans include them6KFFSourceKFF. Costly GLP-1 Drugs Are Rarely Covered for Weight Loss by Marketplace Plans. June 12, 2024.Open the source All sources |
| Medicare | Yes, if you qualify | $50 a month through 20272Centers for Medicare and Medicaid ServicesSourceMedicare.gov. Weight loss drugs: the Medicare GLP-1 Bridge. Checked October 6, 2026.Open the source All sources |
| Medicaid | In some states | Each state decides7KFFSourceKFF. Medicaid Coverage of and Spending on GLP-1s. January 16, 2026.Open the source All sources |
| TRICARE | With Prime or Select | After a prior authorization8Express Scripts, TRICARE Pharmacy ProgramSourceExpress Scripts, TRICARE Pharmacy Program. Are GLP-1 and weight loss medications covered through the TRICARE pharmacy benefit? Checked October 6, 2026.Open the source All sources |
| The VA | Yes, if you qualify | Alongside its MOVE! program9U.S. Department of Veterans AffairsSourceU.S. Department of Veterans Affairs. Weight Management: A VA Clinician's Summary (2025). June 2025.Open the source All sources |
02Why it varies
Why does one plan cover it and another doesn't?
Mostly, it comes down to cost. These medicines are popular and pricey, so each plan weighs them against everything else it pays for. Many large employers that cover them told KFF that more people used them than expected.1KFFSourceKFF. 2025 Employer Health Benefits Survey. October 22, 2025.Open the source All sources
Medicare and Medicaid have their own rules. Medicare drug plans aren't allowed to pay for weight-loss medicines, which is why Medicare set up its own program in 2026. For Medicaid, covering them for weight loss is each state's choice.10U.S. Government Publishing OfficeSourceU.S. Code, Title 42, sections 1395w-102(e)(2) and 1396r-8(d)(2): weight-loss drugs in Medicare Part D and Medicaid.Open the source All sources
Coverage also follows what each medicine is approved for, and some do more than weight loss. Wegovy® is approved to help protect the heart in adults with heart disease. Zepbound® is approved to treat moderate to severe sleep apnea in adults with obesity.11U.S. Food and Drug AdministrationSourceFDA prescribing information for Wegovy®, Zepbound®, Ozempic® and Mounjaro®: Indications and Usage.All sources
So a plan that won't cover them for weight loss may still cover them for those. If either fits you, it's worth mentioning to your clinician.2Centers for Medicare and Medicaid ServicesSourceMedicare.gov. Weight loss drugs: the Medicare GLP-1 Bridge. Checked October 6, 2026.Open the source All sources
And plans change, often once a year, sometimes in your favor. On October 1, 2026, for example, Zepbound® was added back to some of CVS Caremark's drug lists.12Eli Lilly and CompanySourceLilly. Zepbound® savings and insurance options. Checked October 6, 2026.Open the source All sources
03Qualifying
What do plans usually ask for?
Plans that cover GLP-1s for weight loss tend to follow the medicine's label. That usually means a BMI of 30 or more, or 27 or more with a weight-related condition, like high blood pressure.11U.S. Food and Drug AdministrationSourceFDA prescribing information for Wegovy®, Zepbound®, Ozempic® and Mounjaro®: Indications and Usage.All sources3Cigna HealthcareSourceCigna Healthcare. Drug Coverage Policy IP0206: Weight Loss, Glucagon-Like Peptide-1 Agonists (Foundayo™). Effective September 1, 2026.Open the source All sources
Some ask for a little more, like a few months of diet and activity changes first, or joining a lifestyle program. Your clinician notes these on the form.3Cigna HealthcareSourceCigna Healthcare. Drug Coverage Policy IP0206: Weight Loss, Glucagon-Like Peptide-1 Agonists (Foundayo™). Effective September 1, 2026.Open the source All sources1KFFSourceKFF. 2025 Employer Health Benefits Survey. October 22, 2025.Open the source All sources
Most plans also need a prior authorization. That's a request your clinician sends, asking your plan to approve the medicine before it pays.4Novo NordiskSourceNovoCare. Check your coverage for Wegovy®. Checked October 6, 2026.Open the source All sources
It can take up to 10 business days, so ask your clinician's office to send it right away.4Novo NordiskSourceNovoCare. Check your coverage for Wegovy®. Checked October 6, 2026.Open the source All sources
An approval lasts from 30 days to more than a year, depending on your plan.4Novo NordiskSourceNovoCare. Check your coverage for Wegovy®. Checked October 6, 2026.Open the source All sources At renewal, plans usually want to see that it's working. Cigna's and UnitedHealthcare's policies, for example, look for at least 5% of your starting weight lost.3Cigna HealthcareSourceCigna Healthcare. Drug Coverage Policy IP0206: Weight Loss, Glucagon-Like Peptide-1 Agonists (Foundayo™). Effective September 1, 2026.Open the source All sources5UnitedHealthcareSourceUnitedHealthcare. Prior Authorization/Notification, Weight Loss/Appetite Suppression Medication Coverage, program 2026 P 1114-23. Effective October 1, 2026.Open the source All sources
If you've already started, there's good news. Cigna's policy and Medicare's program both go by your BMI from before you began. So the weight you lose doesn't count against you.3Cigna HealthcareSourceCigna Healthcare. Drug Coverage Policy IP0206: Weight Loss, Glucagon-Like Peptide-1 Agonists (Foundayo™). Effective September 1, 2026.Open the source All sources13Centers for Medicare and Medicaid ServicesSourceCMS. Medicare GLP-1 Bridge: Information for Providers. Checked October 6, 2026.Open the source All sources
04Medicare
Does Medicare cover GLP-1s for weight loss?

Yes, if you qualify. Since July 1, 2026, a temporary program called the Medicare GLP-1 Bridge has covered some GLP-1s for $50 a month.2Centers for Medicare and Medicaid ServicesSourceMedicare.gov. Weight loss drugs: the Medicare GLP-1 Bridge. Checked October 6, 2026.Open the source All sources
It covers the Wegovy® shot and pill, Foundayo™ and the Zepbound® KwikPen, and it runs through December 31, 2027.2Centers for Medicare and Medicaid ServicesSourceMedicare.gov. Weight loss drugs: the Medicare GLP-1 Bridge. Checked October 6, 2026.Open the source All sources
You'll need Medicare drug coverage (Part D), plus one of these from before you started a GLP-1:2Centers for Medicare and Medicaid ServicesSourceMedicare.gov. Weight loss drugs: the Medicare GLP-1 Bridge. Checked October 6, 2026.Open the source All sources13Centers for Medicare and Medicaid ServicesSourceCMS. Medicare GLP-1 Bridge: Information for Providers. Checked October 6, 2026.Open the source All sources
A BMI of 35 or more
No other condition needed.
A BMI of 30 or more
With certain types of heart failure, high blood pressure that's hard to control, or chronic kidney disease (stage 3a or higher).
A BMI of 27 or more
With prediabetes, or if you've had a heart attack, a stroke or blocked arteries in your legs or arms.
Have type 2 diabetes, moderate to severe sleep apnea or fatty liver disease? Then you'd go through your own Medicare drug plan instead. It may already cover a GLP-1 for you.2Centers for Medicare and Medicaid ServicesSourceMedicare.gov. Weight loss drugs: the Medicare GLP-1 Bridge. Checked October 6, 2026.Open the source All sources
Getting started is simple, and there's nothing to sign up for. Your clinician sends a prescription to your pharmacy, then fills in a form for Medicare's approval when the pharmacy asks.13Centers for Medicare and Medicaid ServicesSourceCMS. Medicare GLP-1 Bridge: Information for Providers. Checked October 6, 2026.Open the source All sources
Medicare decides within 72 hours and sends you a letter. Then it's $50 a month at the pharmacy, and refills and dose changes don't need a new approval.13Centers for Medicare and Medicaid ServicesSourceCMS. Medicare GLP-1 Bridge: Information for Providers. Checked October 6, 2026.Open the source All sources2Centers for Medicare and Medicaid ServicesSourceMedicare.gov. Weight loss drugs: the Medicare GLP-1 Bridge. Checked October 6, 2026.Open the source All sources
05Checking
How do you check your coverage?
A call to your plan, or a look in its app, tells you most of what you need. Have your card handy. Here's what to ask:
Call the number on your card
Ask if your plan covers the medicine for weight loss, by name: Wegovy®, Zepbound® or Foundayo™. Ask about the shot and the pill too, since they can be covered differently.14Novo NordiskSourceNovoCare. Wegovy® Insurance Coverage Guide. September 2026.Open the source All sources
Ask about prior authorization
If your plan needs one, ask for its criteria in writing, so your clinician knows exactly what to send.14Novo NordiskSourceNovoCare. Wegovy® Insurance Coverage Guide. September 2026.Open the source All sources
Ask what you'd pay
Ask whether it's a copay (a set amount) or coinsurance (a share of the price), and whether your deductible applies first.14Novo NordiskSourceNovoCare. Wegovy® Insurance Coverage Guide. September 2026.Open the source All sources
Jot down the answers
Note who you spoke with and when. It saves time if you need to follow up later.15Centers for Medicare and Medicaid ServicesSourceHealthCare.gov. Internal appeals. Checked October 6, 2026.Open the source All sources
Share them with your clinician
They'll use your plan's criteria to send the prior authorization.14Novo NordiskSourceNovoCare. Wegovy® Insurance Coverage Guide. September 2026.Open the source All sources
06Paying
What will you pay if you're covered?
If your plan covers it, the maker's savings card can lower your share to as little as $25 a month.16Novo NordiskSourceNovoCare. Wegovy® savings offer terms and conditions. Checked October 6, 2026.Open the source All sources12Eli Lilly and CompanySourceLilly. Zepbound® savings and insurance options. Checked October 6, 2026.Open the source All sources
The cards take off up to $100 a month. So a $60 copay becomes $25, and a $300 one becomes $200.16Novo NordiskSourceNovoCare. Wegovy® savings offer terms and conditions. Checked October 6, 2026.Open the source All sources
They're for private insurance, like a plan through work or one you buy yourself. They can't be used with Medicare, Medicaid, TRICARE or the VA.16Novo NordiskSourceNovoCare. Wegovy® savings offer terms and conditions. Checked October 6, 2026.Open the source All sources12Eli Lilly and CompanySourceLilly. Zepbound® savings and insurance options. Checked October 6, 2026.Open the source All sources
07If it's a no
What if your plan won't cover it?

A no from your plan isn't always the final word. First, ask why. Your plan has to tell you, and the reason points to your next step.17Centers for Medicare and Medicaid ServicesSourceHealthCare.gov. How to appeal an insurance company decision. Checked October 6, 2026.Open the source All sources
Was it a medical reason, like a missing note or a question about your BMI? Your clinician can resend the request, or appeal with a letter. You have 180 days to appeal.15Centers for Medicare and Medicaid ServicesSourceHealthCare.gov. Internal appeals. Checked October 6, 2026.Open the source All sources
If the plan still says no, you can ask for an independent review, and your plan has to accept its decision.18Centers for Medicare and Medicaid ServicesSourceHealthCare.gov. External review. Checked October 6, 2026.Open the source All sources
If your plan simply doesn't include weight-loss medicines, that's a benefit choice rather than a medical one. An appeal won't usually change it, but a few other doors are worth trying:18Centers for Medicare and Medicaid ServicesSourceHealthCare.gov. External review. Checked October 6, 2026.Open the source All sources
Ask about another use
If you have heart disease or sleep apnea, ask whether your plan covers Wegovy® or Zepbound® for that.11U.S. Food and Drug AdministrationSourceFDA prescribing information for Wegovy®, Zepbound®, Ozempic® and Mounjaro®: Indications and Usage.All sources
Ask your employer
With a plan through work, your clinician can write to your HR team, asking them to add coverage.4Novo NordiskSourceNovoCare. Check your coverage for Wegovy®. Checked October 6, 2026.Open the source All sources
Compare plans at enrollment
If you can choose a plan for next year, check each one's list of covered drugs before you pick.
08Without insurance
Can you get a GLP-1 without insurance?
Yes. The makers sell their medicines directly, at set cash prices.
The Wegovy® shot is $199 a month for your first two fills, then $349. The Wegovy® pill starts at $149 a month.19Novo NordiskSourceNovoCare. Wegovy® (semaglutide) self-pay prices. Checked October 6, 2026.Open the source All sources
Foundayo™ starts at $149 a month too, and Zepbound® runs from $299 to $449.20Eli Lilly and CompanySourceLillyDirect. Foundayo™ (orforglipron) self-pay prices. Checked October 6, 2026.Open the source All sources21Eli Lilly and CompanySourceLillyDirect. Zepbound® (tirzepatide) self-pay prices. Checked October 6, 2026.Open the source All sources
Compounded semaglutide and tirzepatide cost less again. At the programs we rank, semaglutide runs from $49 to $179 a month, and tirzepatide starts at $89. We checked in late September and early October 2026.
Our guide to compounded GLP-1s explains what they are.
Frequently asked questions.
Why does my plan cover Ozempic® but not Wegovy®?
Plans cover each medicine for what it's approved for, and many leave out weight-loss medicines altogether.1KFFSourceKFF. 2025 Employer Health Benefits Survey. October 22, 2025.Open the source All sources
Ozempic® is approved for type 2 diabetes and Wegovy® for weight loss.
So a plan can cover one and not the other, even though both are semaglutide.
Mounjaro® and Zepbound® work the same way.11U.S. Food and Drug AdministrationSourceFDA prescribing information for Wegovy®, Zepbound®, Ozempic® and Mounjaro®: Indications and Usage.All sources
Does insurance cover compounded GLP-1s?
Usually not.
Plans generally pay for the brand-name medicines, so compounded semaglutide and tirzepatide are paid in cash.
They often cost less than the brands' cash prices.22Cigna HealthcareSourceCigna Healthcare. Drug Coverage Policy IP0251: Compounded Medications. Effective December 15, 2025.Open the source All sources
Can I use my HSA or FSA?
Usually, yes.
The IRS counts prescribed medicines as medical expenses, so a GLP-1 your clinician prescribes generally qualifies.23Internal Revenue ServiceSourceIRS. Publication 502 (2025), Medical and Dental Expenses.Open the source All sources
Several of the programs we rank say their plans are HSA and FSA eligible too.
It's worth checking with your plan's administrator first.
Do online weight-loss programs take insurance?
Some do.
A few help you use your insurance for brand-name medicine, and file the prior authorization for you.
Many others are cash pay, so you don't need insurance at all.
Each of our reviews says how the program handles payment.
The bottom line
Whether insurance covers a GLP-1 comes down to your plan, and a quick call tells you where you stand.
If you're covered, a savings card can trim your share.
If you're not, cash prices and online programs put treatment within reach.
When you're ready, compare programs on our ranking to find one that fits how you want to pay.
By the TreatmentMD editorial team
Medical disclaimerThis content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting any weight-loss program or medication. Individual results may vary.
Sources
- 1KFF. 2025 Employer Health Benefits Survey. October 22, 2025. kff.org
- 2Medicare.gov. Weight loss drugs: the Medicare GLP-1 Bridge. Checked October 6, 2026. medicare.gov
- 3Cigna Healthcare. Drug Coverage Policy IP0206: Weight Loss, Glucagon-Like Peptide-1 Agonists (Foundayo™). Effective September 1, 2026. cigna.com
- 4NovoCare. Check your coverage for Wegovy®. Checked October 6, 2026. novocare.com
- 5UnitedHealthcare. Prior Authorization/Notification, Weight Loss/Appetite Suppression Medication Coverage, program 2026 P 1114-23. Effective October 1, 2026. uhcprovider.com
- 6KFF. Costly GLP-1 Drugs Are Rarely Covered for Weight Loss by Marketplace Plans. June 12, 2024. kff.org
- 7KFF. Medicaid Coverage of and Spending on GLP-1s. January 16, 2026. kff.org
- 8Express Scripts, TRICARE Pharmacy Program. Are GLP-1 and weight loss medications covered through the TRICARE pharmacy benefit? Checked October 6, 2026. express-scripts.com
- 9U.S. Department of Veterans Affairs. Weight Management: A VA Clinician's Summary (2025). June 2025. va.gov
- 10U.S. Code, Title 42, sections 1395w-102(e)(2) and 1396r-8(d)(2): weight-loss drugs in Medicare Part D and Medicaid. govinfo.gov
- 11FDA prescribing information for Wegovy®, Zepbound®, Ozempic® and Mounjaro®: Indications and Usage.
- 12Lilly. Zepbound® savings and insurance options. Checked October 6, 2026. lilly.com
- 13CMS. Medicare GLP-1 Bridge: Information for Providers. Checked October 6, 2026. cms.gov
- 14NovoCare. Wegovy® Insurance Coverage Guide. September 2026. novocare.com
- 15HealthCare.gov. Internal appeals. Checked October 6, 2026. healthcare.gov
- 16NovoCare. Wegovy® savings offer terms and conditions. Checked October 6, 2026. novocare.com
- 17HealthCare.gov. How to appeal an insurance company decision. Checked October 6, 2026. healthcare.gov
- 18HealthCare.gov. External review. Checked October 6, 2026. healthcare.gov
- 19NovoCare. Wegovy® (semaglutide) self-pay prices. Checked October 6, 2026. novocare.com
- 20LillyDirect. Foundayo™ (orforglipron) self-pay prices. Checked October 6, 2026. lilly.com
- 21LillyDirect. Zepbound® (tirzepatide) self-pay prices. Checked October 6, 2026. lilly.com
- 22Cigna Healthcare. Drug Coverage Policy IP0251: Compounded Medications. Effective December 15, 2025. cigna.com
- 23IRS. Publication 502 (2025), Medical and Dental Expenses. irs.gov
Product information
- Zepbound® (tirzepatide) is a prescription-only injectable medication FDA-approved for chronic weight management in adults with obesity, or adults with overweight who have at least one weight-related medical condition. It is also approved for the treatment of moderate to severe obstructive sleep apnea in adults with obesity, and should be used in combination with a reduced-calorie diet and increased physical activity.
- Ozempic® (semaglutide) is a prescription-only injectable medication approved by the U.S. Food and Drug Administration (FDA) for the treatment of type 2 diabetes. It is not FDA-approved for weight loss; however, weight reduction has been observed in some individuals with type 2 diabetes using the medication.
- Mounjaro® (tirzepatide) is a prescription-only injectable medication FDA-approved for the treatment of type 2 diabetes. It is not FDA-approved for weight loss; however, weight reduction has been observed in some individuals using the medication.
- Wegovy® (semaglutide) is a prescription-only injectable medication FDA-approved for chronic weight management in adults with obesity, or adults with at least one weight-related medical condition, when used alongside a reduced-calorie diet and increased physical activity.
- All medications require a medical evaluation and prescription from a licensed healthcare provider. Individual results may vary.
Important safety information
- Compounded semaglutide and tirzepatide are prepared by state-licensed pharmacies and are not FDA approved. The FDA does not review their safety, effectiveness or quality, and clinical trial results for brand-name drugs do not carry over to them.
- Semaglutide and tirzepatide carry a boxed warning for a risk of thyroid C-cell tumors, based on animal studies, and are not for anyone with a personal or family history of medullary thyroid carcinoma (MTC) or MEN2, or who is pregnant. Other warnings include pancreatitis, gallbladder problems, and a higher risk of low blood sugar when combined with insulin or a sulfonylurea. The most common side effects are digestive, such as nausea, vomiting, diarrhea and constipation.
- This is a high-level summary, not a complete list. A licensed clinician will review your health history to decide whether a GLP-1 medication is right for you.








